Novantrone and haemoglobin decreased Patient Reports March 20, 2010

Novantrone Side Effects Report #6089777-X
Novantrone side effect was reported by a Physician from UNITED STATES on Feb 06, 2009. Male patient, 82 years of age, weighting 147.7 lb, was diagnosed with prostate cancer metastatic, myalgia and was treated with Novantrone. After drug was administered, patient experienced the following side effects: adrenal neoplasm, asthenia, bile duct obstruction, biopsy liver abnormal, blood bicarbonate decreased, blood pressure systolic increased, body temperature decreased, haemoglobin decreased, heart rate increased. Novantrone dosage: 23 MG, 1 IN 21 DAYS, INTRAVENOUS. During the same period patient was treated with CETUXIMAB, ALLOPURINOL, VITAMIN E, CENTRUM SILVER, MEVACOR, TYLENOL, ACETYLSALICYLIC ACID SRT, OSTEOBIFLEX. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #6089778-1
Novantrone side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 05, 2009. Male patient, 78 years of age, weighting 193.5 lb, was diagnosed with prostate cancer  and was treated with Novantrone. After drug was administered, patient experienced the following side effects: acute myocardial infarction, coronary artery disease , coronary artery occlusion, gastrointestinal haemorrhage, haematocrit decreased, haemoglobin decreased, hyperlipidaemia, hypotension, injection site thrombosis. Novantrone dosage: 25.2 MG, 1 IN 21 DAYS; INTRAVENOUS. During the same period patient was treated with CETUXIMAB, PREDNISONE, VITAMIN, DARVOCET, SUN CHLORELLA. Patient was hospitalized and became disabled. Patient recovered.

Novantrone Side Effects Report #6133189-7
Novantrone side effect was reported by a Physician from UNITED STATES on Mar 09, 2009. Male patient, 62 years of age, weighting 207.2 lb, was diagnosed with prostate cancer , prostate cancer metastatic and was treated with Novantrone. After drug was administered, patient experienced the following side effects: abscess rupture, blood pressure diastolic decreased, cellulitis , febrile neutropenia, haematocrit decreased, haemoglobin decreased, platelet count decreased, pseudomonas infection, septic embolus. Novantrone dosage: 25 MG, 1 IN 3 WEEKS, INTRAVENOUS (NOT OTHERWISE SPECIFED). During the same period patient was treated with CETUXIMAB, OXYBUTYNIN CHLORIDE, PROSED, HYDROCHLOROTHIAZIDE, LISINOPRIL, ATENOLOL. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5732035-0
Novantrone side effect was reported by a Physician from UNITED KINGDOM on Apr 22, 2008. Male patient, 74 years of age, was diagnosed with multiple sclerosis , prostate cancer  and was treated with Novantrone. After drug was administered, patient experienced the following side effects: dilatation ventricular, dyspnoea exertional, ejection fraction decreased, fluid overload, haemoglobin decreased, oedema. Novantrone dosage: unknown. During the same period patient was treated with ABIRATERONE ACETATE, ZOLADEX, ASPIRIN, EPLERENONE, DEXAMETHASONE. Patient recovered.


Novantrone Side Effects Report #5261968-7
Novantrone side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 27, 2007. Female patient, 64 years of age, was diagnosed with multiple sclerosis  and was treated with Novantrone. After drug was administered, patient experienced the following side effects: diarrhoea, haemoglobin decreased, ulcer , urinary tract infection , weight decreased. Novantrone dosage: unknown. During the same period patient was treated with ATENOLOL, ZOCOR, ZOLOFT, CLONAPIN, BACTRIM. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #4832654-X
Novantrone side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 07, 2005. Male patient, 46 years of age, was diagnosed with multiple sclerosis  and was treated with Novantrone. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Novantrone dosage: 12 MG/M2, 1 IN 3 MONTHS, INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with REBIF, ANZEMET. Patient recovered.

Novantrone Side Effects Report #4990694-4
Novantrone side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 18, 2006. Female patient, 27 years of age, was diagnosed with multiple sclerosis  and was treated with Novantrone. After drug was administered, patient experienced the following side effects: haemoglobin decreased, platelet count decreased, white blood cell count decreased. Novantrone dosage: 18 MG, ONCE, INTRAVENOUS; 1 COURSE. During the same period patient was treated with REBIF. Patient recovered.

Novantrone Side Effects Report #4608880-1
Novantrone side effect was reported by a Consumer or non-health professional from on Feb 28, 2005. Male patient, 50 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Novantrone. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, haemoglobin decreased, platelet count decreased. Novantrone dosage: 18 MG, 1 IN 1 DAYS, INTRAVENOUS. During the same period patient was treated with TRETINOIN, FLUCONAZOLE, LEVOFLOXACIN, PREDNISONE, PANTOPRAZOLE, ETOPOSIDE. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5218785-3
Novantrone side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 18, 2007. Male patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with Novantrone. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, brain oedema, cerebral haemorrhage, haemoglobin decreased, international normalised ratio increased, subarachnoid haemorrhage, therapeutic response decreased, thrombocytopenia, white blood cell count decreased. Novantrone dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYTARABINE. Patient recovered.


Novantrone Side Effects Report #5274475-2
Novantrone side effect was reported by a Health Professional from UNITED STATES on Mar 06, 2007. Male patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with Novantrone. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, brain oedema, cerebral haemorrhage, confusional state, disorientation, haemoglobin decreased, headache , international normalised ratio increased, no therapeutic response. Novantrone dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYTARABINE. Patient recovered.

Novantrone Side Effects Report #5475215-4
Novantrone side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 14, 2007. Male patient, 60 years of age, weighting 123.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Novantrone. After drug was administered, patient experienced the following side effects: blood culture positive, haemoglobin decreased, neutropenia, platelet count decreased, pneumonia , pseudomonas infection, refusal of treatment by patient, white blood cell count decreased. Novantrone dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYTARABINE. Patient died on 09/05/2007.

Novantrone Side Effects Report #4927815-5
Novantrone side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 13, 2006. Female patient, 56 years of age, weighting 106.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Novantrone. After drug was administered, patient experienced the following side effects: asthenia, chills, diarrhoea, dizziness , escherichia bacteraemia, febrile neutropenia, haemoglobin decreased, nausea , red blood cell count decreased. Novantrone dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYTARABINE, LEVOFLOXACIN, VALTREX, IMODIUM, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5330182-9
Novantrone side effect was reported by a Health Professional from UNITED STATES on May 03, 2007. Female patient, 55 years of age, weighting 185.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Novantrone. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematocrit decreased, haemoglobin decreased, platelet count decreased, pyrexia, white blood cell count decreased. Novantrone dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYTARABINE. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5442842-X
Novantrone side effect was reported by a Health Professional from UNITED STATES on Aug 16, 2007. Female patient, 55 years of age, weighting 185.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Novantrone. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematocrit decreased, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Novantrone dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYTARABINE. Patient was hospitalized. Patient recovered.


Novantrone Side Effects Report #5291916-5
Novantrone side effect was reported by a Consumer or non-health professional from ITALY on Mar 26, 2007. Female patient, 63 years of age, weighting 154.3 lb, was treated with Novantrone. After drug was administered, patient experienced the following side effects: haemoglobin decreased, lung infection, platelet count decreased, red blood cell count decreased, respiratory failure, staphylococcal infection , white blood cell count decreased. Novantrone dosage: 12 MG. During the same period patient was treated with GEMTUZUMAB, CYTARABINE, ETOPOSIDE, LEVOFLOXACIN. Patient died on 02/02/2005.

Novantrone Side Effects Report #5062548-9
Novantrone side effect was reported by a Consumer or non-health professional from UNITED STATES on July 13, 2006. Female patient, 63 years of age, weighting 154.3 lb, was treated with Novantrone. After drug was administered, patient experienced the following side effects: haemoglobin decreased, lung infection, platelet count decreased, respiratory failure, staphylococcal infection . Novantrone dosage: 12 MG. During the same period patient was treated with GEMTUZUMAB, CYTARABINE, ETOPOSIDE, LEVOFLOXACIN. Patient died on 02/02/2005.

Novantrone Side Effects Report #5266725-3
Novantrone side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 01, 2007. Male patient, 56 years of age, was treated with Novantrone. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood alkaline phosphatase abnormal, febrile neutropenia, gingival bleeding, haemoglobin decreased, hypersensitivity, hypoalbuminaemia, lymphocyte count decreased, malignant neoplasm progression. Novantrone dosage: unknown. During the same period patient was treated with MYLOTARG, CYTARABINE, ENOCITABINE, KELFIPRIM, ITRACONAZOLE. Patient recovered.

Novantrone Side Effects Report #5074368-X
Novantrone side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 20, 2006. Female patient, 54 years of age, was treated with Novantrone. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, lymphocyte count decreased, neutropenic sepsis, platelet count decreased, red blood cell count decreased. Novantrone dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, TRETINOIN. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5081955-1
Novantrone side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 31, 2006. Female patient, 54 years of age, was treated with Novantrone. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, lymphocyte count decreased, neutropenic sepsis, platelet count decreased, red blood cell count decreased. Novantrone dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, TRETINOIN. Patient was hospitalized. Patient recovered.